Method for Preparing Polydopamine Nanomotor Using Urease and Use of Same
Summary
USPTO granted Patent US12599571B2 to POSTECH Research and Business Development Foundation for a biocompatible polydopamine nanomotor using urease. The nanomotor is designed to infiltrate bladder walls in biological environments and remain inside the bladder for extended periods. The patent includes 10 claims covering the preparation method and therapeutic applications.
What changed
USPTO issued Patent US12599571B2 to POSTECH Research and Business Development Foundation covering a method for preparing polydopamine nanomotors using urease and their use for bladder infiltration. The invention relates to biocompatible nanomotors capable of penetrating bladder walls and sustained residence within the bladder for therapeutic delivery.
For affected parties, this patent grant establishes exclusive rights for POSTECH in the United States for the claimed nanomotor technology and methods. Competitors developing similar urease-powered polydopamine nanomotors for bladder therapy or anticancer applications may need to design around these claims or seek licensing arrangements.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method for preparing polydopamine nanomotor using urease, and use of same
Grant US12599571B2 Kind: B2 Apr 14, 2026
Assignee
POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
Inventors
Sei Kwang Hahn, Hyun Sik Choi, Sang Baie Shin
Abstract
The present invention relates to a biocompatible polydopamine nanomotor capable of infiltrating a bladder wall in a biological environment and remaining inside a bladder for a long time.
CPC Classifications
A61K 9/51 A61K 45/06 A61K 47/18 A61K 47/69 A61K 9/5138 A61K 31/00 A61K 47/6925 A61P 13/10 A61P 35/00 B82Y 5/00
Filing Date
2020-03-10
Application No.
17905821
Claims
10
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.